UPDATE - Canadian Urological Association guideline: Male lower urinary tract symptoms/benign prostatic hyperplasia.
作者信息
Elterman Dean, Aubé-Peterkin Mélanie, Evans Howard, Elmansy Hazem, Meskawi Malek, Zorn Kevin C, Bhojani Naeem
机构信息
Division of Urology, University of Toronto, Toronto, ON, Canada.
Division of Urology, McGill University, Montreal, QC, Canada.
出版信息
Can Urol Assoc J. 2022 Aug;16(8):245-256. doi: 10.5489/cuaj.7906.
Abstract
摘要
相似文献
1
UPDATE - Canadian Urological Association guideline: Male lower urinary tract symptoms/benign prostatic hyperplasia.更新 - 加拿大泌尿外科协会指南：男性下尿路症状/良性前列腺增生
Can Urol Assoc J. 2022 Aug;16(8):245-256. doi: 10.5489/cuaj.7906.
2
Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update.加拿大泌尿外科协会男性下尿路症状/良性前列腺增生（MLUTS/BPH）指南：2018年更新版
Can Urol Assoc J. 2018 Oct;12(10):303-312. doi: 10.5489/cuaj.5616.
3
Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.植物疗法对5种良性前列腺增生/下尿路症状健康状态效用评分的影响。
J Urol. 2008 Jan;179(1):220-5. doi: 10.1016/j.juro.2007.08.152. Epub 2007 Nov 14.
4
Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?下尿路症状、良性前列腺增生/良性前列腺肿大与勃起功能障碍：这些病症与血管功能障碍有关吗？
Int J Urol. 2014 Sep;21(9):856-64. doi: 10.1111/iju.12501. Epub 2014 Jun 15.
5
Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility.遗传序列变异与下尿路症状严重程度和前列腺癌易感性相关。
J Urol. 2013 Mar;189(3):845-8. doi: 10.1016/j.juro.2012.11.044. Epub 2012 Nov 13.
6
Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.良性前列腺增生和下尿路症状的可改变风险因素：老问题的新方法
J Urol. 2007 Aug;178(2):395-401. doi: 10.1016/j.juro.2007.03.103. Epub 2007 Jun 11.
7
Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia.男性下尿路症状和良性前列腺增生临床指南。
Int J Urol. 2017 Oct;24(10):716-729. doi: 10.1111/iju.13401. Epub 2017 Jul 26.
8
Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.慢性前列腺炎与良性前列腺增生的严重程度和进展、下尿路症状以及急性尿潴留风险相关。
J Urol. 2016 Nov;196(5):1493-1498. doi: 10.1016/j.juro.2016.06.090. Epub 2016 Jul 1.
9
Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?糖尿病与良性前列腺增生/下尿路症状——我们了解多少？
J Urol. 2009 Dec;182(6 Suppl):S32-7. doi: 10.1016/j.juro.2009.07.088.
10
Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.每日一次他达拉非联合非那雄胺治疗良性前列腺增生所致下尿路症状和前列腺增生的 6 个月疗效和安全性。
J Urol. 2014 Mar;191(3):727-33. doi: 10.1016/j.juro.2013.09.059. Epub 2013 Oct 2.
引用本文的文献
1
Comparative Outcomes of Open Simple Prostatectomy in Men with or Without Prior History of Transurethral Resection of the Prostate.有或无经尿道前列腺切除术病史男性行开放性单纯前列腺切除术的比较结果
Urol Res Pract. 2025 Jul 29;51(4):136-140. doi: 10.5152/tud.2025.24053.
2
Surgical treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: an analysis and meta-synthesis of available guidelines.良性前列腺梗阻继发下尿路症状的外科治疗：现有指南的分析与综合评价
BMC Urol. 2025 Apr 24;25(1):99. doi: 10.1186/s12894-025-01788-6.
3
Assessing the methodologic heterogeneity of Canadian Urological Association guidelines Adoption of the GRADE approach (2018-2023).评估加拿大泌尿外科学会指南采用GRADE方法（2018 - 2023年）的方法学异质性。
Can Urol Assoc J. 2025 Jun;19(6):173-180. doi: 10.5489/cuaj.8926.
4
Prostate cancer screening in transgender patients Why current Canadian screening policies need to be better tailored to our patients.跨性别患者的前列腺癌筛查 为何当前加拿大的筛查政策需要更好地适应我们的患者。
Can Urol Assoc J. 2025 Jun;19(6):202-204. doi: 10.5489/cuaj.9005.
5
Urinary Retention After GreenLight Laser Photoselective Vaporization of the Prostate (GLL.PVP) Surgery for Benign Prostatic Hyperplasia (BPH): A 3-6 Month Retrospective Follow-Up Study.良性前列腺增生（BPH）患者接受绿激光选择性前列腺汽化术（GLL.PVP）后尿潴留：一项3 - 6个月的回顾性随访研究。
Cureus. 2024 Nov 13;16(11):e73585. doi: 10.7759/cureus.73585. eCollection 2024 Nov.
6
First-Time Successful Trial Without Catheter (TWOC) After GreenLight Laser Photoselective Vaporization of the Prostate (GLL PVP) Surgery for an Enlarged Prostate.前列腺增生症经绿激光选择性汽化术（GLL PVP）治疗后首次无导尿管成功试验（TWOC）
Cureus. 2024 Nov 4;16(11):e72982. doi: 10.7759/cureus.72982. eCollection 2024 Nov.
7
Efficacy of Rezūm water vapor therapy for the treatment of catheter-dependent urinary retention A single-center, Canadian experience.Rezum水蒸气疗法治疗导尿管依赖型尿潴留的疗效：加拿大单中心经验
Can Urol Assoc J. 2025 Jan;19(1):E18-E24. doi: 10.5489/cuaj.8808.
8
Risks and side effects in the medical management of benign prostatic hyperplasia.良性前列腺增生症药物治疗中的风险与副作用
Prostate Int. 2024 Jun;12(2):57-64. doi: 10.1016/j.prnil.2023.11.004. Epub 2023 Dec 2.
9
Long-term outcomes after treatment with Optilume BPH Four-year results from the EVEREST study.使用Optilume BPH治疗后的长期结果：EVEREST研究的四年结果。
Can Urol Assoc J. 2024 Nov;18(11):E319-E325. doi: 10.5489/cuaj.8737.
10
An analysis of benign prostatic hyperplasia surgical treatment reimbursement trends across Canada Examining provincial changes over the recent decade with comparison to cost of living changes.加拿大良性前列腺增生症手术治疗报销趋势分析：考察近十年各省的变化情况，并与生活成本变化作比较。
Can Urol Assoc J. 2024 Aug;18(8):268-273. doi: 10.5489/cuaj.8638.
本文引用的文献
1
Evaluating the acceptability of an online patient decision aid for the surgical management of lower urinary tract symptoms secondary to benign prostatic hyperplasia.评估一种在线患者决策辅助工具对良性前列腺增生继发下尿路症状手术治疗的可接受性。
Can Urol Assoc J. 2021 Aug;15(8):247-254. doi: 10.5489/cuaj.7492.
2
Robotic-assisted versus open simple prostatectomy: Results from a systematic review and meta-analysis of comparative studies.机器人辅助与开放性单纯前列腺切除术：系统评价和荟萃分析比较研究的结果。
Investig Clin Urol. 2021 Nov;62(6):631-640. doi: 10.4111/icu.20210297.
3
Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.多中心随机对照假手术治疗良性前列腺增生症中度至重度下尿路症状的水蒸气热疗 5 年最终结果
J Urol. 2021 Sep;206(3):715-724. doi: 10.1097/JU.0000000000001778. Epub 2021 Apr 19.
4
Impact of the presence of a median lobe on functional outcomes of greenlight photovaporization of the prostate (PVP): an analysis of the Global Greenlight Group (GGG) Database.中叶存在对前列腺绿光汽化术（PVP）功能结局的影响：全球绿光集团（GGG）数据库分析。
World J Urol. 2021 Oct;39(10):3881-3889. doi: 10.1007/s00345-020-03529-w. Epub 2021 Jan 3.
5
The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial.用于治疗良性前列腺增生继发下尿路症状的iTind临时植入镍钛诺装置：一项多中心、随机、对照试验。
Urology. 2021 Jul;153:270-276. doi: 10.1016/j.urology.2020.12.022. Epub 2020 Dec 26.
6
Prostatic Artery Embolization in Refractory Hematuria of Prostatic Origin.前列腺动脉栓塞治疗前列腺源性难治性血尿。
Tech Vasc Interv Radiol. 2020 Sep;23(3):100694. doi: 10.1016/j.tvir.2020.100694. Epub 2020 Oct 6.
7
Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride.非那雄胺治疗患者的自杀意念和心理不良事件研究。
JAMA Dermatol. 2021 Jan 1;157(1):35-42. doi: 10.1001/jamadermatol.2020.3385.
8
3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction.第二代临时植入式镍钛诺装置治疗良性前列腺增生引起的男性下尿路症状的 3 年疗效。
Prostate Cancer Prostatic Dis. 2021 Jun;24(2):349-357. doi: 10.1038/s41391-020-00281-5. Epub 2020 Oct 1.
9
Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study.男性下尿路症状治疗中临时植入性镍钛诺装置（iTind）的尿控和性功能：MT-06 研究的 6 个月中期结果。
World J Urol. 2021 Jun;39(6):2037-2042. doi: 10.1007/s00345-020-03418-2. Epub 2020 Aug 26.
10
Randomised trial of bipolar resection vs holmium laser enucleation vs Greenlight laser vapo-enucleation of the prostate for treatment of large benign prostate obstruction: 3-years outcomes.随机对照试验：双极前列腺切除术与钬激光前列腺剜除术和绿激光前列腺汽化切除术治疗大体积良性前列腺梗阻的 3 年疗效比较。
BJU Int. 2020 Dec;126(6):731-738. doi: 10.1111/bju.15161. Epub 2020 Sep 30.
Zotero 插件